|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.115 CAD | +21.05% |
|
-4.17% | -36.11% |
| Apr. 25 | Transcript : Valeo Pharma Inc. - Shareholder/Analyst Call | |
| Mar. 22 | Valeo Pharma Inc. Announces Appointment of Al Moghaddam to Board of Directors | CI |
Valeo Pharma Inc. reported earnings results for the first quarter ended January 31, 2024. For the first quarter, the company reported sales was CAD 13.54 million compared to CAD 13.16 million a year ago. Net loss was CAD 6.87 million compared to CAD 6.25 million a year ago.
Basic loss per share from continuing operations was CAD 0.08 compared to CAD 0.08 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -36.11% | 8.29M | |
| +25.83% | 661B | |
| +27.00% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B |
VALEO PHARMA INC. 
